161 related articles for article (PubMed ID: 32268068)
1. Genome-Wide CRISPRi-Based Identification of Targets for Decoupling Growth from Production.
Li S; Jendresen CB; Landberg J; Pedersen LE; Sonnenschein N; Jensen SI; Nielsen AT
ACS Synth Biol; 2020 May; 9(5):1030-1040. PubMed ID: 32268068
[TBL] [Abstract][Full Text] [Related]
2. CRISPRi/dCpf1-mediated dynamic metabolic switch to enhance butenoic acid production in Escherichia coli.
Ji X; Zhao H; Zhu H; Zhu K; Tang SY; Lou C
Appl Microbiol Biotechnol; 2020 Jun; 104(12):5385-5393. PubMed ID: 32338294
[TBL] [Abstract][Full Text] [Related]
3. CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli.
Byun G; Yang J; Seo SW
Nucleic Acids Res; 2023 May; 51(9):4650-4659. PubMed ID: 36999618
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli.
Hashemi A
World J Microbiol Biotechnol; 2020 Jun; 36(7):96. PubMed ID: 32583135
[TBL] [Abstract][Full Text] [Related]
5. Redirecting Metabolic Flux via Combinatorial Multiplex CRISPRi-Mediated Repression for Isopentenol Production in Escherichia coli.
Tian T; Kang JW; Kang A; Lee TS
ACS Synth Biol; 2019 Feb; 8(2):391-402. PubMed ID: 30681833
[TBL] [Abstract][Full Text] [Related]
6. Filamentation and restoration of normal growth in Escherichia coli using a combined CRISPRi sgRNA/antisense RNA approach.
Mückl A; Schwarz-Schilling M; Fischer K; Simmel FC
PLoS One; 2018; 13(9):e0198058. PubMed ID: 30204770
[TBL] [Abstract][Full Text] [Related]
7. CRISPR interference-guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli.
Kim SK; Seong W; Han GH; Lee DH; Lee SG
Microb Cell Fact; 2017 Nov; 16(1):188. PubMed ID: 29100516
[TBL] [Abstract][Full Text] [Related]
8. Multiplex Generation, Tracking, and Functional Screening of Substitution Mutants Using a CRISPR/Retron System.
Lim H; Jun S; Park M; Lim J; Jeong J; Lee JH; Bang D
ACS Synth Biol; 2020 May; 9(5):1003-1009. PubMed ID: 32348672
[TBL] [Abstract][Full Text] [Related]
9. Making point mutations in Escherichia coli BL21 genome using the CRISPR-Cas9 system.
Wang X; He J; Le K
FEMS Microbiol Lett; 2018 Jul; 365(14):. PubMed ID: 29596631
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-based genome editing for simultaneous interference with gene expression and protein stability.
Martínez V; Lauritsen I; Hobel T; Li S; Nielsen AT; Nørholm MHH
Nucleic Acids Res; 2017 Nov; 45(20):e171. PubMed ID: 28981713
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protein and biochemical production using CRISPRi-based growth switches.
Li S; Jendresen CB; Grünberger A; Ronda C; Jensen SI; Noack S; Nielsen AT
Metab Eng; 2016 Nov; 38():274-284. PubMed ID: 27647432
[TBL] [Abstract][Full Text] [Related]
12. A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens.
Choudhery S; DeJesus MA; Srinivasan A; Rock J; Schnappinger D; Ioerger TR
PLoS Comput Biol; 2024 May; 20(5):e1011408. PubMed ID: 38768228
[TBL] [Abstract][Full Text] [Related]
13. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
Cho S; Shin J; Cho BK
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
[TBL] [Abstract][Full Text] [Related]
14. RNA-guided single/double gene repressions in Corynebacterium glutamicum using an efficient CRISPR interference and its application to industrial strain.
Park J; Shin H; Lee SM; Um Y; Woo HM
Microb Cell Fact; 2018 Jan; 17(1):4. PubMed ID: 29316926
[TBL] [Abstract][Full Text] [Related]
15. A dual sgRNA library design to probe genetic modifiers using genome-wide CRISPRi screens.
Guna A; Page KR; Replogle JM; Esantsi TK; Wang ML; Weissman JS; Voorhees RM
BMC Genomics; 2023 Oct; 24(1):651. PubMed ID: 37904134
[TBL] [Abstract][Full Text] [Related]
16. Impact of CRISPR interference on strain development in biotechnology.
Schultenkämper K; Brito LF; Wendisch VF
Biotechnol Appl Biochem; 2020 Jan; 67(1):7-21. PubMed ID: 32064678
[TBL] [Abstract][Full Text] [Related]
17. Tunable translation-level CRISPR interference by dCas13 and engineered gRNA in bacteria.
Kim G; Kim HJ; Kim K; Kim HJ; Yang J; Seo SW
Nat Commun; 2024 Jun; 15(1):5319. PubMed ID: 38909033
[TBL] [Abstract][Full Text] [Related]
18. CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production.
Kim SK; Han GH; Seong W; Kim H; Kim SW; Lee DH; Lee SG
Metab Eng; 2016 Nov; 38():228-240. PubMed ID: 27569599
[TBL] [Abstract][Full Text] [Related]
19. Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi).
Hawkins JS; Wong S; Peters JM; Almeida R; Qi LS
Methods Mol Biol; 2015; 1311():349-62. PubMed ID: 25981485
[TBL] [Abstract][Full Text] [Related]
20. A plasmid toolset for CRISPR-mediated genome editing and CRISPRi gene regulation in Escherichia coli.
Jervis AJ; Hanko EKR; Dunstan MS; Robinson CJ; Takano E; Scrutton NS
Microb Biotechnol; 2021 May; 14(3):1120-1129. PubMed ID: 33710766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
